Loading clinical trials...
Loading clinical trials...
PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation (PTNM) System in Patients With OAB
Conditions
Interventions
NURO System PTNM Therapy
Locations
11
United States
Pinellas Urology, Inc.
St. Petersburg, Florida, United States
NorthShore University Health System
Evanston, Illinois, United States
Mount Auburn Hospital
Cambridge, Massachusetts, United States
Advanced Urogynecology of Michigan, P.C.
Dearborn, Michigan, United States
Metro Urology
Woodbury, Minnesota, United States
Urology Center Research Institute, LLC
Englewood, New Jersey, United States
Start Date
September 1, 2016
Primary Completion Date
November 21, 2017
Completion Date
November 21, 2017
Last Updated
January 14, 2019
NCT06789406
NCT05362292
NCT07193407
NCT07195656
NCT07209397
NCT05799313
Lead Sponsor
MedtronicNeuro
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions